JP Morgan Private Wealth Advisors’s Arcturus Therapeutics ARCT Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,857	Closed	-$20K	–	1292
2017 Q3	$20K	Sell	2,857 -1,714	-37%	-$12.9K	﹤0.01%	1231
2017 Q2	$35K	Buy	4,571 +285	+7%	+$2.29K	﹤0.01%	1217
2017 Q1	$34K	Buy	4,286 +1,429	+50%	+$13.2K	﹤0.01%	1316
2016 Q4	$42K	Hold	2,857	–	–	﹤0.01%	1228
2016 Q3	$49K	Hold	2,857	–	–	﹤0.01%	1211
2016 Q2	$90K	Hold	2,857	–	–	﹤0.01%	1210
2016 Q1	$76K	Hold	2,857	–	–	﹤0.01%	1157
2015 Q4	$126K	Hold	2,857	–	–	﹤0.01%	1065
2015 Q3	$121K	Buy	+2,857	New	+$150K	﹤0.01%	981
2015 Q2	–	Sell	-2,857	Closed	-$113K	–	1052
2015 Q1	$113K	Sell	2,857 -2,429	-46%	-$107K	﹤0.01%	1082
2014 Q4	$138K	Buy	+5,286	New	+$168K	﹤0.01%	1035

Other funds holding ARCT

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

JP Morgan Private Wealth Advisors's ARCT Position: Q4 2017 in Review

JP Morgan Private Wealth Advisors sold out of Arcturus Therapeutics (ARCT) in Q4 2017, closing a stake of 2,857 shares — an estimated $20K sold.

JP Morgan Private Wealth Advisors first reported a position in ARCT in Q4 2014 and held it in 11 quarters. The position peaked at $138K in Q4 2014. 19 funds tracked by Wall St. Rank hold ARCT as of Q4 2017.

JP Morgan Private Wealth Advisors reported no remaining Arcturus Therapeutics position as of Q4 2017 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 2,857 Arcturus Therapeutics shares in Q4 2017, an estimated $20K.
JP Morgan Private Wealth Advisors first reported a position in Arcturus Therapeutics in Q4 2014 and held it in 11 quarters.
JP Morgan Private Wealth Advisors's Arcturus Therapeutics position peaked at $138K in Q4 2014.
19 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2017.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.